|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 270, Issue 6 1371-R1379, Copyright © 1996 by American Physiological Society
ARTICLES |
K. L. Teff and K. Engelman
Monell Chemical Senses Center, Philadelphia, Pennsylvania 19104, USA.
In animals, bypassing the oropharyngeal receptors by intragastric administration of glucose results in glucose intolerance. To determine whether the absence of oral sensory stimulation alters glucose tolerance in humans, we monitored plasma levels of glucose and hormones after intragastric administration of glucose, with and without subjects tasting food. Plasma glucose area under the curve (AUC) was significantly lower after oral sensory stimulation (3,433 +/- 783 vs. 5,643 +/- 1,397 mg.dl-1. 195 min-1; P < 0.03; n = 8). Insulin and C-peptide AUCs were higher during the first one-half of the sampling period (insulin, 5,771 +/- 910 vs. 4,295 +/- 712 microU. ml-1.75 min-1; P < 0.05; C-peptide, 86 +/- 10 vs. 66 +/- 9 ng.ml-1. 75 min-1; P < 0.03) and lower during the second one-half of the sampling period compared with the control condition (1,010 +/- 233 vs. 2,106 microU.ml-1. 120 min-1; P < 0.025; 31 +/- 8 vs. 56 +/- 18 ng.ml-1. 120 min-1; P < 0.05; insulin and C-peptide, respectively). Oral sensory stimulation markedly increased plasma glucagon compared with the control condition (1,258 +/- 621 vs. -2,181 +/- 522 pg.ml-1. 195 min-1; P < 0.002). These data provide evidence in humans that oral sensory stimulation influences glucose metabolism and suggest that the mechanisms elicited by this cephalic stimulation are necessary for normal glucose homeostasis.
This article has been cited by other articles:
![]() |
N. Someya and N. Hayashi Chewing and taste increase blood velocity in the celiac but not the superior mesenteric arteries Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1921 - R1925. [Abstract] [Full Text] [PDF] |
||||
![]() |
M D. Robertson, A. O Mason, and K. N Frayn Timing of vagal stimulation affects postprandial lipid metabolism in humans Am. J. Clinical Nutrition, July 1, 2002; 76(1): 71 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Cherrington, D. Sindelar, D. Edgerton, K. Steiner, and O. P. McGuinness Physiological Consequences of Phasic Insulin Release in the Normal Animal Diabetes, February 1, 2002; 51(90001): S103 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Teff and R. R. Townsend Early phase insulin infusion and muscarinic blockade in obese and lean subjects Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1999; 277(1): R198 - R208. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Singleton, C. Heiser, K. Jamesen, and R. D. Mattes Sweetener Augmentation of Serum Triacylglycerol during a Fat Challenge Test in Humans J. Am. Coll. Nutr., April 1, 1999; 18(2): 179 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Jensen and E. J. Messina C-peptide induces a concentration-dependent dilation of skeletal muscle arterioles only in presence of insulin Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1223 - H1228. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |